“Courtside with the Chair” is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Peter Dean, Keri Shafer, and Jonathan Edelson to discuss the emergence of Pediatric Sports Cardiology. Dr. Kim moderates the discussion about important issues within pediatric sports cardiology that differentiates from the clinical thinking around adult athletes. The conversation over two parts focuses on the need for the field of pediatric sports cardiology, what defines a ‘pediatric athlete’, considerations for screening this population, differences with shared decision-making compared to adult athletes, and gaps in knowledge. 

 Subscribe to CardiaCast | Claim CME Credit 

“Courtside with the Chair” is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Peter Dean, Keri Shafer, and Jonathan Edelson to discuss the emergence of Pediatric Sports Cardiology. Dr. Kim moderates the discussion about important issues within pediatric sports cardiology that differentiates from the clinical thinking around adult athletes. The conversation over two parts focuses on the need for the field of pediatric sports cardiology, what defines a ‘pediatric athlete’, considerations for screening this population, differences with shared decision-making compared to adult athletes, and gaps in knowledge. 

 Subscribe to CardiaCast | Claim CME Credit  

Echocardiography (Echo) and point-of-care ultrasound (POCUS) play a critical role in the cardiac intensive Care Unit (CICU). In this episode, our expert cardiologists Drs. Rosy Thachil, Shashank Sinha, Smadar Kort and Eugene Yuriditsky examine the latest advancements, techniques, and clinical applications of Echo and POCUS in managing critically ill cardiac patients. Learn how these powerful imaging tools can enhance diagnostic accuracy, provide real-time data, guide therapeutic interventions, and improve patient outcomes in the high-stakes environment of the CICU. Whether you're a seasoned cardiologist or a healthcare professional new to critical care cardiology, there is much to learn from these valuable insights and practical tips for optimizing the use of Echo and POCUS. 

Related References: 

1. Kirkpatrick JN, Grimm R, Johri AM, et al. Recommendations for echocardiography laboratories participating in cardiac point of care cardiac ultrasound (POCUS) and critical care echocardiography training: report from the American Society of Echocardiography.  J Am Soc Echocardiogr 2020;33:409-422.e4. 

 Subscribe to CardiaCast |  

Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based solutions to the everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific Pharmacist focus. In this episode, Andrea Price, MS, AACC hosts Tomasz Jurga, PharmD, BCPS, BCACP, BCCP, HF-Cert, AACC; Lydia Tran, PharmD, BCPS and Bruce Warden, PharmD, BCPS, FNLA, FASPC to discuss the role of the pharmacists of the care team for lipid management.   

 Subscribe to CardiaCast  

Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based solutions to the everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific Pharmacist focus. In this episode, Andrea Price, MS, AACC hosts Lydia Tran, PharmD, BCPS and Sushma Dey, PharmD, BCACP to discuss the role of the pharmacists on the care team for hypertension management.   

Subscribe to CardiaCast  

In this installment of Atrial Fibrillation (AFib) and Antiarrhythmic Drugs (AADs) series, Dr. Suneet Mittal interviews Dr. Jeff Healey about evidence supporting the guidelines and how they compare to previous guidelines. Listen as Dr. Healey analyzes the utilization of AADs based on the 2023 guidelines. 

This podcast is part of Early Onset of Atrial Fibrillation & the Contemporary Use of Antiarrhythmic Drugs grant initiative. 

Educational grant support is provided by Sanofi. Click here for more: https://learn.acc.org/Page/LearnAntiarrhythmicDrugsforAF  

Subscribe to CardiaCast | Claim CME Credit 

Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members are new, or new to cardiology, offering practical team-based solutions to the everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific Pharmacist focus. In this episode, Andrea Price, MS, AACC hosts Anastasia Armbruster, PharmD, FACC, BCCP and Megan Labreck, PharmD, BCPS, CACP to discuss the most recent atrial fibrillation (Afib) guidelines and what the documents mean to a pharmacist working on a cardiac arrhythmia care team.  

Subscribe to CardiaCast  

In this episode of CardiaCast, hypertrophic cardiomyopathy (HCM) expert Dr. Matthew Martinez will discuss with Dr. Michelle Kittleson recommendations for early diagnosis in the 2024 HCM guideline and review the latest clinical and real-world trial data for new (mavacamten) and emerging (aficamten) cardiac myosin inhibitors.  

This CardiaCast is part of an educational series, “2024 Update to the AHA/ACC HCM Guideline: Expert Interpretation for Application to Practice,” which includes a total of three ACC CardiaCasts and an accredited #MedX. The series is produced by the American College of Cardiology Foundation and Med-IQ and supported by an educational grant from Bristol Myers Squibb. Exploring HCM Diagnosis and Treatment Options: The New Frontier of Cardiac Myosin Inhibitors (acc.org) 

 Suggested Materials:   

1. Olivotto I, Oreziak A, Barriales-Villa R, et al; EXPLORER-HCM study investigators. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2020;396:759-69. Erratum in: Lancet 2020;396:758.  

1. Desai MY, Owens A, Wolski K, et al. Mavacamten in patients with hypertrophic cardiomyopathy referred for septal reduction: week 56 results from the VALOR-HCM randomized clinical trial. JAMA Cardiol 2023;8:968-77.  

1. Maron MS, Masri A, Nassif ME, et al; SEQUOIA-HCM Investigators. Aficamten for symptomatic obstructive hypertrophic cardiomyopathy. N Engl J Med 2024;390:1849-61.  

Special Edition: PharmD Appreciation: “PulseCheck” is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based solutions to everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific PharmD focus. In this episode, Andrea Price, MS, AACC hosts Jessie Dunne, PharmD, BCCP, BCPC and Orly Vardeny, PharmD, MS, FAHA, FHFSA to discuss the most recent heart failure guidelines, expert consensus publication, and what these documents mean to a pharmacist working on a heart failure care team.   

Subscribe to CardiaCast  

In this episode of CardiaCast, hypertrophic cardiomyopathy (HCM) expert Dr. Matthew Martinez will discuss with Dr. Cesar Herrera challenges that exist in Latin America related to the application of the recently issued guideline, “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.”  

This CardiaCast is part of an educational series, “2024 Update to the AHA/ACC HCM Guideline: Expert Interpretation for Application to Practice,” which includes a total of three ACC CardiaCasts and an accredited #MedX. The series is produced by the American College of Cardiology Foundation and Med-IQ and supported by an educational grant from Bristol Myers Squibb. Exploring HCM Diagnosis and Treatment Options: The New Frontier of Cardiac Myosin Inhibitors (acc.org) 

Subscribe to CardiaCast